Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-29 Sale |
2021-03-31 12:30 pm |
Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. |
124,447 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec |
215,000 | $0 | 215,000 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-22 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec |
474,350 | $0 | 474,350 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec |
241,650 | $0 | 241,650 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:50 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec |
179,000 | $0 | 179,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 5:43 pm |
N/A 2033-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec |
155,000 | $0 | 155,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:37 pm |
N/A 2032-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. General Counsel, Corporate Sec |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-04 4:27 pm |
N/A 2031-05-03 |
Eledon Pharmaceuticals Inc. | ELDN | Smith Bryan E. See Remarks |
158,500 | $0 | 158,500 (Direct) |
View |
| 2021-01-07 Tax Withholding |
2021-01-08 6:29 pm |
N/A N/A |
Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. |
4,761 | $16.09 | 124,447 (Direct) |
View |
| 2020-05-01 Option Award |
2020-05-04 4:55 pm |
N/A N/A |
Urovant Sciences Ltd. | UROV | Smith Bryan E. GC/Urovant Sciences, Inc. |
77,606 | $0 | 127,606 (Direct) |
View |